Evidence map›Paper›PMID 41736931›Full record

ArticlePhysics and imaging in radiation oncology2026

Effects of breath-hold reproducibility on proton and photon lung cancer stereotactic body radiotherapy.

Nils Olovsson, Kenneth Wikström, Anna Flejmer, Alexandru Dasu

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nils OlovssonDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Kenneth WikströmDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Anna FlejmerDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Alexandru DasuDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Breath-hold can mitigate respiratory motion in lung cancer radiotherapy. Reduced motion could be especially beneficial for proton therapy which is more sensitive to geometrical perturbations than photon therapy. However, failure to reproduce the breath-hold tumor position could lessen this advantage. In this study, effects of reproducibility were investigated for 3D and 4D robust optimized proton and photon therapy. Materials and methods: Fourteen patients with early stage lung cancer, imaged with a single breath-hold computed tomography, were included. Reproducibility variations were included in the treatment planning and simulated with image deformations. Further, additional larger variations were included in the evaluation.Three photon and three proton therapy treatment plans were robustly optimized for the same intended dose and compared using probabilistic evaluation. One 3D method only accounted for patient shifts. A second 3D method accounted for breath-hold variations using larger patient shifts. The final 4D method used additional planning images. Results: Protons resulted in reduced dose to organs of interest but with higher spread in target dose compared with photons. Mean heart dose was reduced, 90% probability of 6.7 Gy with photons compared with 0.3 Gy for protons for 4D planning. Decreased reproducibility affected tumor dose ranges. However, the 90% probability of median tumor dose remained stable. Conclusions: Reduction in dose to organs of interest was demonstrated with proton therapy. Using 4D compared with 3D optimization did not result in more robust plans. Larger breath-hold variability than anticipated during planning had a minor effect on the target dose.

Indexed as

Breath-holdLung cancerProbabilistic evaluationProton therapyRobust optimizationSBRT

Identifiers

PMID41736931
PMCPMC12926599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.